HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inosine monophosphate and inosine differentially regulate endotoxemia and bacterial sepsis.

Abstract
Inosine monophosphate (IMP) is the intracellular precursor for both adenosine monophosphate and guanosine monophosphate and thus plays a central role in intracellular purine metabolism. IMP can also serve as an extracellular signaling molecule, and can regulate diverse processes such as taste sensation, neutrophil function, and ischemia-reperfusion injury. How IMP regulates inflammation induced by bacterial products or bacteria is unknown. In this study, we demonstrate that IMP suppressed tumor necrosis factor (TNF)-α production and augmented IL-10 production in endotoxemic mice. IMP exerted its effects through metabolism to inosine, as IMP only suppressed TNF-α following its CD73-mediated degradation to inosine in lipopolysaccharide-activated macrophages. Studies with gene targeted mice and pharmacological antagonism indicated that A2A , A2B, and A3 adenosine receptors are not required for the inosine suppression of TNF-α production. The inosine suppression of TNF-α production did not require its metabolism to hypoxanthine through purine nucleoside phosphorylase or its uptake into cells through concentrative nucleoside transporters indicating a role for alternative metabolic/uptake pathways. Inosine augmented IL-β production by macrophages in which inflammasome was activated by lipopolysaccharide and ATP. In contrast to its effects in endotoxemia, IMP failed to affect the inflammatory response to abdominal sepsis and pneumonia. We conclude that extracellular IMP and inosine differentially regulate the inflammatory response.
AuthorsMarianna Lovászi, Zoltán H Németh, William C Gause, Jennet Beesley, Pál Pacher, György Haskó
JournalFASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J) Vol. 35 Issue 11 Pg. e21935 (11 2021) ISSN: 1530-6860 [Electronic] United States
PMID34591327 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2021 Federation of American Societies for Experimental Biology.
Chemical References
  • 9-chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline
  • Adenosine A2 Receptor Antagonists
  • Adenosine A3 Receptor Antagonists
  • Adora2a protein, mouse
  • IL10 protein, mouse
  • Quinazolines
  • Receptor, Adenosine A2A
  • Receptor, Adenosine A2B
  • Receptor, Adenosine A3
  • Triazoles
  • Tumor Necrosis Factor-alpha
  • adora2b protein, mouse
  • Interleukin-10
  • Inosine Monophosphate
  • Inosine
Topics
  • Adenosine A2 Receptor Antagonists (pharmacology)
  • Adenosine A3 Receptor Antagonists (pharmacology)
  • Animals
  • Disease Models, Animal
  • Endotoxemia (metabolism)
  • Inosine (metabolism)
  • Inosine Monophosphate (metabolism)
  • Interleukin-10 (biosynthesis)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Pneumonia, Pneumococcal (metabolism, microbiology)
  • Quinazolines (pharmacology)
  • Receptor, Adenosine A2A (metabolism)
  • Receptor, Adenosine A2B (metabolism)
  • Receptor, Adenosine A3 (metabolism)
  • Signal Transduction (drug effects)
  • Streptococcus pneumoniae
  • Triazoles (pharmacology)
  • Tumor Necrosis Factor-alpha (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: